TipRanks
Advertisement
Advertisement

BFRI Stock Latest News

Biofrontera Gains FDA Approval for Ameluz Skin Cancer Use
Company AnnouncementsBiofrontera Gains FDA Approval for Ameluz Skin Cancer Use
11d ago
8K
BFRI
Biofrontera announces FDA approval of Ameluz supplemental new drug application
PremiumThe Fly
Biofrontera announces FDA approval of Ameluz supplemental new drug application
11d ago
BFRI
FDA approves label update for Biofrontera’s Ameluz Gel
PremiumThe Fly
FDA approves label update for Biofrontera’s Ameluz Gel
15d ago
BFRI
Biofrontera Earnings Call Highlights Growth Amid Legal Risks
PremiumCompany Announcements
Biofrontera Earnings Call Highlights Growth Amid Legal Risks
1M ago
BFRI
Is BFRI a Buy, Before Earnings?
PremiumPre-Earnings
Is BFRI a Buy, Before Earnings?
2M ago
BFRI
BFRI Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBFRI Upcoming Earnings Report: What to Expect?
2M ago
BFRI
Biofrontera’s Acne PDT Trial Completion: What Investors Should Watch Next
Premium
Company Announcements
Biofrontera’s Acne PDT Trial Completion: What Investors Should Watch Next
3M ago
BFRI
Biofrontera’s Phase III Actinic Keratosis Study Nears Data Payoff for Investors
Premium
Company Announcements
Biofrontera’s Phase III Actinic Keratosis Study Nears Data Payoff for Investors
3M ago
BFRI
Biofrontera Shareholders Approve Director Elections and Equity Plan
PremiumCompany Announcements
Biofrontera Shareholders Approve Director Elections and Equity Plan
3M ago
8K
BFRI
Biofrontera Earnings Call Highlights Growth And Risks
PremiumCompany Announcements
Biofrontera Earnings Call Highlights Growth And Risks
4M ago
BFRI
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
PremiumThe Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
4M ago
AMT
BAP
Biofrontera downgraded to Speculative Buy from Buy at Benchmark
PremiumThe Fly
Biofrontera downgraded to Speculative Buy from Buy at Benchmark
4M ago
BFRI
Is BFRI a Buy, Before Earnings?
PremiumPre-EarningsIs BFRI a Buy, Before Earnings?
5M ago
BFRI
Biofrontera Earnings Call: Profits Rise, Risks Remain
Premium
Company Announcements
Biofrontera Earnings Call: Profits Rise, Risks Remain
6M ago
BFRI
Biofrontera reports Q4 revenue $17.1M vs. $12.6M last year
Premium
The Fly
Biofrontera reports Q4 revenue $17.1M vs. $12.6M last year
6M ago
BFRI
Biofrontera, Inc. (BFRI) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Biofrontera, Inc. (BFRI) Q4 Earnings Cheat Sheet
6M ago
BFRI
Biofrontera Reports Positive Phase 2b Acne Trial Results
PremiumCompany Announcements
Biofrontera Reports Positive Phase 2b Acne Trial Results
7M ago
8K
BFRI
Biofrontera reports Phase 2b results of Ameluz PDT in acne vulgaris
PremiumThe Fly
Biofrontera reports Phase 2b results of Ameluz PDT in acne vulgaris
7M ago
BFRI
Biofrontera Wins Key PTAB Ruling in Sun Patent Dispute
PremiumCompany Announcements
Biofrontera Wins Key PTAB Ruling in Sun Patent Dispute
7M ago
8K
BFRI
Biofrontera reports USPTO decision on Sun Pharma’s challenged claims
PremiumThe FlyBiofrontera reports USPTO decision on Sun Pharma’s challenged claims
7M ago
BFRI
Biofrontera announces database lock of Phase 1 PK study of Ameluz
Premium
The Fly
Biofrontera announces database lock of Phase 1 PK study of Ameluz
7M ago
BFRI
Biofrontera announces FDA acceptance of sNDA for Ameluz PDT
Premium
The Fly
Biofrontera announces FDA acceptance of sNDA for Ameluz PDT
8M ago
BFRI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >